Veracyte Inc (Veracyte) is a molecular diagnostics company that specializes in genomic testing for cancer diagnosis and treatment. The company’s products include Afirma genomic sequencing classifier for thyroid cancer, Decipher prostate genomic classifier targets prostate cancer; the prosigna breast cancer assay, which treats breast cancer; Decipher bladder genomic classifier targets bladder cancer; Percepta nasal swab test treats lung cancer; and Lymphmark targets diffuse large B-cell lymphoma. Its MRD technology platform delivers high-performing cancer tests by broad genomic and clinical data, deep bioinformatic and AI capabilities, and a powerful evidence-generation engine. The company operates in the US, the Netherlands, France and Israel. Veracyte is headquartered in San Francisco, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Veracyte Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Exact Sciences Corp Company Overview
- Exact Sciences Corp Company Snapshot
- Exact Sciences Corp Pipeline Products and Ongoing Clinical Trials Overview
- Exact Sciences Corp - Pipeline Analysis Overview
- Business Description
- Exact Sciences Corp - Key Facts
- Exact Sciences Corp - Major Products and Services
- Exact Sciences Corp Pipeline Products by Development Stage
- Exact Sciences Corp Ongoing Clinical Trials by Trial Status
- Exact Sciences Corp Pipeline Products Overview
- Blood Based Colorectal Cancer Screening Test
- Blood Based Colorectal Cancer Screening Test Product Overview
- Blood-based Lung Cancer Screening Test
- Blood-based Lung Cancer Screening Test Product Overview
- Circulating Tumor DNA Test - Colorectal Cancer
- Circulating Tumor DNA Test - Colorectal Cancer Product Overview
- Circulating Tumor DNA Test - Colorectal Cancer Clinical Trial
- Diagnostic Test - Hepatocellular Carcinoma
- Diagnostic Test - Hepatocellular Carcinoma Product Overview
- DNA Integrity Assay
- DNA Integrity Assay Product Overview
- Liquid Biopsy Test - Bladder Cancer
- Liquid Biopsy Test - Bladder Cancer Product Overview
- Liquid Biopsy Test - Breast Cancer
- Liquid Biopsy Test - Breast Cancer Product Overview
- Liquid Biopsy Test - Cervical Cancer
- Liquid Biopsy Test - Cervical Cancer Product Overview
- Liquid Biopsy Test - Esophageal Cancer
- Liquid Biopsy Test - Esophageal Cancer Product Overview
- Liquid Biopsy Test - Kidney Cancer
- Liquid Biopsy Test - Kidney Cancer Product Overview
- Liquid Biopsy Test - Lymphoma
- Liquid Biopsy Test - Lymphoma Product Overview
- Liquid Biopsy Test - Melanoma
- Liquid Biopsy Test - Melanoma Product Overview
- Liquid Biopsy Test - Ovarian Cancer
- Liquid Biopsy Test - Ovarian Cancer Product Overview
- Liquid Biopsy Test - Pancreatic Cancer
- Liquid Biopsy Test - Pancreatic Cancer Product Overview
- Liquid Biopsy Test - Prostate Cancer
- Liquid Biopsy Test - Prostate Cancer Product Overview
- Liquid Biopsy Test - Stomach Cancer
- Liquid Biopsy Test - Stomach Cancer Product Overview
- Liquid Biopsy Test - Uterine Cancer
- Liquid Biopsy Test - Uterine Cancer Product Overview
- MAESTRO Test
- MAESTRO Test Product Overview
- Multi-Cancer Earlier Detection Test
- Multi-Cancer Earlier Detection Test Product Overview
- Multi-Cancer Earlier Detection Test Clinical Trial
- Multi-Cancer Screening Test
- Multi-Cancer Screening Test Product Overview
- Oncofind
- Oncofind Product Overview
- Oncoguard Esophagus Test
- Oncoguard Esophagus Test Product Overview
- Oncosearch
- Oncosearch Product Overview
- Oncoverify
- Oncoverify Product Overview
- Oncowatch
- Oncowatch Product Overview
- TARDIS Test
- TARDIS Test Product Overview
- Exact Sciences Corp - Key Competitors
- Exact Sciences Corp - Key Employees
- Exact Sciences Corp - Key Employee Biographies
- Exact Sciences Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Exact Sciences Corp, Recent Developments
- Jun 02, 2026: ASCO26: Abbott demonstrates MRD test benefit in TNBC recurrence
- May 27, 2026: ACS Guideline Reaffirms Abbott Leadership in Noninvasive Colorectal Cancer Screening
- May 26, 2026: Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026
- Apr 30, 2026: Abbott to Highlight Expanding Cancer Diagnostic Portfolio and Clinical Evidence at Digestive Disease Week (DDW) 2026
- Apr 17, 2026: New Data at AACR 2026 Demonstrate Advancements in Cancerguard Multi-Cancer Early Detection Test
- Mar 24, 2026: John Stamos and Jodie Sweetin Reunite for “The (Second) Talk” With Cologuard Tests, Encouraging Colon Cancer Screening
- Mar 17, 2026: Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026
- Mar 13, 2026: Workflow Services Supports Walgreens National Colorectal Cancer Initiative to Close Screening Gaps; Leverages Cologuard Tests to Expand Reach
- Feb 13, 2026: Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results
- Feb 03, 2026: Exact Sciences Praises Passage of Legislation Establishing Medicare Coverage Pathway for Multi-Cancer Early Detection Tests
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Exact Sciences Corp Pipeline Products and Ongoing Clinical Trials Overview
- Exact Sciences Corp Pipeline Products by Equipment Type
- Exact Sciences Corp Pipeline Products by Indication
- Exact Sciences Corp Ongoing Clinical Trials by Trial Status
- Exact Sciences Corp, Key Facts
- Exact Sciences Corp, Major Products and Services
- Exact Sciences Corp Number of Pipeline Products by Development Stage
- Exact Sciences Corp Pipeline Products Summary by Development Stage
- Exact Sciences Corp Ongoing Clinical Trials by Trial Status
- Exact Sciences Corp Ongoing Clinical Trials Summary
- Blood Based Colorectal Cancer Screening Test - Product Status
- Blood Based Colorectal Cancer Screening Test - Product Description
- Blood-based Lung Cancer Screening Test - Product Status
- Blood-based Lung Cancer Screening Test - Product Description
- Circulating Tumor DNA Test - Colorectal Cancer - Product Status
- Circulating Tumor DNA Test - Colorectal Cancer - Product Description
- Circulating Tumor DNA Test - Colorectal Cancer - CORRECT-MRD I: First Colorectal Cancer Clinical Validation Study to Predict Recurrence Using a Circulating Tumor DNA Assay to Detect Minimal Residual Disease
- Circulating Tumor DNA Test - Colorectal Cancer - CORRECT-MRD II: Second Colorectal Cancer Clinical Validation Study to Predict Recurrence Using a Circulating Tumor DNA Assay to Detect Minimal Residual Disease
- Diagnostic Test - Hepatocellular Carcinoma - Product Status
- Diagnostic Test - Hepatocellular Carcinoma - Product Description
- DNA Integrity Assay - Product Status
- DNA Integrity Assay - Product Description
- Liquid Biopsy Test - Bladder Cancer - Product Status
- Liquid Biopsy Test - Bladder Cancer - Product Description
- Liquid Biopsy Test - Breast Cancer - Product Status
- Liquid Biopsy Test - Breast Cancer - Product Description
- Liquid Biopsy Test - Cervical Cancer - Product Status
- Liquid Biopsy Test - Cervical Cancer - Product Description
- Liquid Biopsy Test - Esophageal Cancer - Product Status
- Liquid Biopsy Test - Esophageal Cancer - Product Description
- Liquid Biopsy Test - Kidney Cancer - Product Status
- Liquid Biopsy Test - Kidney Cancer - Product Description
- Liquid Biopsy Test - Lymphoma - Product Status
- Liquid Biopsy Test - Lymphoma - Product Description
- Liquid Biopsy Test - Melanoma - Product Status
- Liquid Biopsy Test - Melanoma - Product Description
- Liquid Biopsy Test - Ovarian Cancer - Product Status
- Liquid Biopsy Test - Ovarian Cancer - Product Description
- Liquid Biopsy Test - Pancreatic Cancer - Product Status
- Liquid Biopsy Test - Pancreatic Cancer - Product Description
- Liquid Biopsy Test - Prostate Cancer - Product Status
- Liquid Biopsy Test - Prostate Cancer - Product Description
- Liquid Biopsy Test - Stomach Cancer - Product Status
- Liquid Biopsy Test - Stomach Cancer - Product Description
- Liquid Biopsy Test - Uterine Cancer - Product Status
- Liquid Biopsy Test - Uterine Cancer - Product Description
- MAESTRO Test - Product Status
- MAESTRO Test - Product Description
- Multi-Cancer Earlier Detection Test - Product Status
- Multi-Cancer Earlier Detection Test - Product Description
- Multi-Cancer Earlier Detection Test - Falcon - The Exact Sciences Multicancer Early Detection (MCED) Real World Evidence (RWE) Registry
- Multi-Cancer Screening Test - Product Status
- Multi-Cancer Screening Test - Product Description
- Oncofind - Product Status
- Oncofind - Product Description
- Oncoguard Esophagus Test - Product Status
- Oncoguard Esophagus Test - Product Description
- Oncosearch - Product Status
- Oncosearch - Product Description
- Oncoverify - Product Status
- Oncoverify - Product Description
- Oncowatch - Product Status
- Oncowatch - Product Description
- TARDIS Test - Product Status
- TARDIS Test - Product Description
- Exact Sciences Corp, Key Employees
- Exact Sciences Corp, Key Employee Biographies
- Exact Sciences Corp, Subsidiaries
- Glossary
- Exact Sciences Corp Pipeline Products by Equipment Type
- Exact Sciences Corp Pipeline Products by Development Stage
- Exact Sciences Corp Ongoing Clinical Trials by Trial Status
